Inotuzumab
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22. This naked antibody can be used to synthesize antibody-active molecule conjugators [Inotuzumab ozogamicin] and to study acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Product Specifications
CAS Number
1660159-36-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
Approximately 146.48 kDa.
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
ADC Antibody
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
